Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Pifzer

- PMLiVE

Coronavirus disruption scuppers Curium Pharma sale

London-based private equity firm CapVest will wait for market to improve

- PMLiVE

COVID-19: Novel coronavirus remains stable on surfaces for hours

Researchers find virus stays on surfaces for several hours to days

- PMLiVE

UK biotech Synairgen to begin COVID-19 trial of lead candidate

Company enters the race to find a therapeutic as virus cases rise

- PMLiVE

Novartis launches $20m COVID-19 response fund

Financial grants will be issued to most impacted communities

Courageous Conversations ep.5: Virtual Meetings During the COVID-19 Pandemic

Impetus Digital

Impetus Digital official statement on COVID-19

At Impetus Digital, the health and wellbeing of our staff, clients, advisors, and their families is always our top priority. Recently, we have seen high numbers of advisors cancel their...

Impetus Digital

- PMLiVE

Biogen joins COVID-19 efforts with $10m support fund

Funds will be used to address 'immediate critical needs'

- PMLiVE

First patients dosed with Moderna’s COVID-19 vaccine

More pharma players also join vaccine development efforts

- PMLiVE

UK ramps up measures to combat coronavirus spread

New advice encourages ‘social-distancing’ as cases expected to soar

- PMLiVE

Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19

The interleukin-6 inhibitor will be evaluated in critically ill patients

- PMLiVE

CEPI says $2bn is needed for COVID-19 vaccine development

Funding will be used to take candidates through all stages of development

- PMLiVE

Did Trump offer CureVac $1bn for COVID-19 vaccine rights?

Media reports claim Trump administration tried to secure exclusive rights

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links